Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > BioSante Pharmaceuticals Names Joy A. Thomas

BioSante Pharmaceuticals, Inc. (AMEX:BPA) today announced the appointment of Joy A. Thomas as vice president of corporate development. Ms. Thomas will be integral to BioSante implementing its corporate development strategies, including collaborations and licensing.

BioSante Pharmaceuticals Names Joy A. Thomas

LINCOLNSHIRE, IL | Posted on September 5th, 2007

Ms. Thomas comes to BioSante after 13 years with Baxter Healthcare Corporation where she was most recently Senior Director, Global Strategy & Business Development for its Renal Division. Earlier she was Director, Strategic Marketing and Planning for its Medication Delivery Division. Ms. Thomas holds a Bachelor of Science degree in Finance and Russian from the University of Illinois, and a Master of Business Administration in International Business and Finance from the University of Chicago.

"We are very pleased to have Joy Thomas joining us at this exciting time for BioSante," said Stephen M. Simes, BioSante's president and chief executive officer. "Joy's experience and expertise will be invaluable in assessing BioSante's strategic alternatives in view of the excellent progress we have made, especially related to FDA clarity on the development of LibiGel® in the treatment of female sexual dysfunction. We remain dedicated to our objective of maximizing stockholder value and believe Joy will be integral to this endeavor."


About BioSante Pharmaceuticals, Inc.
BioSante is developing a pipeline of hormone therapy products to treat both men and women. These hormone therapy products are gel formulations for transdermal administration that deliver bio-identical estradiol and testosterone. BioSante's lead products include Elestrin™ (estradiol gel) developed through U.S. Food and Drug Administration (FDA) approval by BioSante indicated for the treatment of moderate-to-severe vasomotor symptoms associated with menopause, marketed in the U.S. by Bradley Pharmaceuticals, Inc., BioSante's licensee, and LibiGel® (transdermal testosterone gel) in Phase III clinical development by BioSante for the treatment of female sexual dysfunction (FSD). Also in development is Bio-T-Gel™, a testosterone gel for male hypogonadism, and an oral contraceptive in Phase II clinical development using BioSante patented technology. The current market in the U.S. for estrogen and testosterone products is approximately $2.5 billion and for oral contraceptives approximately $3.0 billion. The company also is developing its calcium phosphate nanotechnology (CaP) for novel vaccines, including hepatitis B, avian flu and biodefense vaccines for toxins such as anthrax, as well as a system for delivering drugs via alternative routes of administration and for aesthetic medicine.

For more information, please click here

BioSante Pharmaceuticals, Inc.
Phillip Donenberg
(847) 478-0500

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Electric fields remove nanoparticles from blood with ease November 24th, 2015

Production of Nanocapsules Containing Omega-3 Powder in Iran November 24th, 2015

Using light-force to study single molecules November 23rd, 2015

Breakthrough allows tracking of single molecules in 3-D with nanoscale accuracy:New method builds on Nobel Prize-winning technique, with exciting implications for understanding the inner workings of cells and neurons November 23rd, 2015


Electric fields remove nanoparticles from blood with ease November 24th, 2015

Researchers find new, inexpensive way to clean water from oil sands production November 24th, 2015

Production of Nanocapsules Containing Omega-3 Powder in Iran November 24th, 2015

Tandem solar cells are simply better: Higher efficiency thanks to perovskite magic crystal November 24th, 2015

Appointments/Promotions/New hires/Resignations/Deaths

Kerstin Kleese van Dam Named Director of Brookhaven Lab's Computational Science Initiative September 26th, 2015

QD Vision Names Display Industry Veteran Mustafa Ozgen as CEO to Support Aggressive Growth and Market Expansion September 15th, 2015

National Space Society Welcomes Janet Ivey As New NSS Governor: Janet Ivey of Janet's Planet is NOW IN ORBIT as a member of the Board of Governors of the National Space Society August 27th, 2015

National Space Society Welcomes Geoff Notkin As New NSS Governor August 26th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic